Navigating PI-RADS 3 Lesions: Reducing Uncertainty and Guiding Prostate Cancer Diagnostic Decision Making

The authors aim to address the diagnostic challenges associated with PI-RADS 3 lesions, which have an ambiguous likelihood of clinically significant prostate cancer, leading to potential overdiagnosis and overtreatment. They discuss factors contributing to the prevalence of these lesions and propose strategies, such as structured reporting and the integration of ancillary biomarkers, to enhance diagnostic accuracy and guide clinical decision-making. By understanding the limitations and evolving management strategies for PI-RADS 3 lesions, the authors seek to improve patient outcomes and reduce unnecessary interventions.